A report yesterday from the United Kingdom's Health Security Agency (HSA) shows sexually transmitted Shigella infections are rising again in England after falling during the COVID-19 pandemic.
A study yesterday in The Lancet Infectious Diseases describes an ongoing outbreak of sexually transmitted, extensively drug-resistant (XDR) Shigella sonnei in the United Kingdom.
A study conducted at five acute care hospitals adds further evidence of the role the hospital environment plays in Clostridioides difficile infection (CDI), researchers reported today in the American Journal of Infection Control.
A study of 42 million US patient visits for antibiotic-inappropriate acute respiratory infections (ARIs) found that more than 10% received an antibiotic prescription, with providers in urgent care clinics and southern states among the most likely prescribers, US researchers reported this week in Infection Control & Hospital Epidemiology.
Analysis reveals that 171 of the isolates are closely related and form a distinct lineage.
Researchers in Finland report in a study yesterday in Clinical Microbiology and Infection that the use of oral antibiotics before joint replacement surgery is common and may lower the risk for periprosthetic joint infection (PJI), but indiscriminate use of antibiotics before such surgeries cannot be recommended.
Emerging strains have a reduced susceptibility to ciprofloxacin, a main treatment option.
Nearly a quarter of Shigella isolates in New York City showed decreased susceptibility or resistance.
A UK study this week notes highly resistant Shigella sonnei isolates from men who have sex with men (MSM) who had engaged in high-risk activities, while Canadian scientists report a different antibiotic-resistant Shigella strain in a man with HIV, according to separate reports in Emerging Infectious Diseases.
Two reports today detail evidence of rising antibiotic-resistant Shigella among men who have sex with men.
